Baxter to Divest Vantive Kidney Care to the Carlyle Group for $3.8B
Pending regulatory approval, this transfer to a global investment company will take place in late 2024 or early 2025. Baxter will use the proceeds to pay down debt.
Read the full article » | Posted 08-16-2024
Related Articles
- AAKP: 49th National Patient Meeting September 25-27, 2024, in Orlando Posted 09-12-2024
- NephU’s Hot Topics in Nephrology Podcast Includes Diality’s New Home HD Machine Posted 09-12-2024
- MEI Consultant Beth Witten to Speak at AKF Online Dialysis at Home Event on October 5 Posted 09-12-2024
- Assisted Home HD in Qatar Avoids Ambulance Transport in Vulnerable Patients Posted 08-16-2024